Liposarcoma – Epidemiology – Overview

  • The total number of diagnosed incident cases of liposarcoma in the countries under study will increase by 17% over the 20-year forecast period.
  • For the year 2022, liposarcoma of the HNTE accounts for 3,374 diagnosed incident cases in the countries under study; liposarcoma of the abdomen and thoracic viscera accounts for 3,282 cases; and liposarcoma of the retroperitoneum accounts for 1,699 cases.
  • Of the countries considered in this analysis, Germany has the highest incidence of liposarcoma of the HNTE: 0.5 cases per 100,000 per year in 2022.
  • Approximately 92% of newly diagnosed incident cases of liposarcoma of the HNTE, the abdomen and thoracic viscera, and the retroperitoneum are amenable to resection.

launch Related Market Assessment Reports